LRRC75A-AS1 targets miR-199b-5p/PDCD4 axis to repress multiple myeloma

Pang Quantang; Wang Yanyan; Bi Dapeng; Lu Hongyu

首页> 外文期刊>Cancer biology & therapy >LRRC75A-AS1 targets miR-199b-5p/PDCD4 axis to repress multiple myeloma

【24h】

LRRC75A-AS1 targets miR-199b-5p/PDCD4 axis to repress multiple myeloma

机译：LRRC75A-AS1针对miR-199b-5p / pdcd4轴来压抑多个骨髓瘤

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background

机译：None

著录项

来源
《Cancer biology & therapy》 |2020年第12期|共9页
作者
Pang Quantang; Wang Yanyan; Bi Dapeng; Lu Hongyu;
展开▼
作者单位

Rongcheng Peoples Hosp Shandong Prov Dept Orthopaed Rongcheng Shandong Peoples R China;

Rongcheng Peoples Hosp Shandong Prov Dept Neurol Rongcheng 264300 Shandong Peoples R China;

Jining Second Peoples Hosp Shandong Prov Dept Orthopaed Jining Shandong Peoples R China;

Rongcheng Peoples Hosp Shandong Prov Dept Neurol Rongcheng 264300 Shandong Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
multiple myeloma; miR-199b-5p; LRRC75A-AS1; PDCD4;

机译：多发性骨髓瘤;mir-199b-5p;lrrc75a-as1;pdcd4;

相似文献

外文文献
中文文献
专利

1. Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma [J] . Dustin Rizzieri, Barry Paul, Yubin Kang 癌症转移与治疗（英文版） . 2019,第004期
2. Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma [J] . Dustin Rizzieri, Barry Paul, Yubin Kang 癌症转移与治疗：英文版 . 2019,第004期
3. Let-7b-5p regulates proliferation and apoptosis in multiple myeloma by targeting IGF1R [J] . Honghai Xu, Cong Liu, Yuelin Zhang, 生物化学与生物物理学报：英文版 . 2014,第011期
4. miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4 [J] . Wu Yaxun, Zhu Xinghua, Shen Rong, Pathology Research and Practice . 2019,第11期

机译：MiR-182通过靶向PDCD4有助于多发性骨髓瘤中的细胞粘附介导的耐药性
5. Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis [J] . Wu Linlin, Xia Liang, Chen Xiaowen, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2021,第1期

机译：长期非编码RNA LINC01003通过靶向MIR-33A-5P / PIM1轴来抑制多发性骨髓瘤的发育
6. Long noncoding RNA UCA1 regulates proliferation and apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for the activation of JAK2/STAT3 pathway [J] . J.-L. Li, X.-L. Liu, S.-F. Guo, European review for medical and pharmacological sciences. . 2019,第21期

机译：长非编码RNA UCA1通过靶向miR-331-3p / IL6R轴激活JAK2 / STAT3途径来调节多发性骨髓瘤的增殖和凋亡
7. CRF-LSTM Text Mining Method Unveiling the Pharmacological Mechanism of Off-target Side Effect of Anti-Multiple Myeloma Drugs [C] . Kaiyin Zhou, Ke Ding, Sheng Zhang, Annual meeting of the Association for Computational Linguistics . 2018

机译：CRF-LSTM文本挖掘方法揭示抗多发性骨髓瘤药物脱靶副作用的药理机制
8. Pre-Clinical Strategies to Overcome Drug-Resistant Multiple Myeloma: Predictive Transcriptomics and Targeting the Myeloma Epigenome [D] . Harding, Taylor Stiver. 2018

机译：克服毒性多发性骨髓瘤的前临床策略：预测转录组织和靶向骨髓瘤外形组织
9. CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ/ Stat3 axis [O] . Linlin Yang, Bowen Wu, Zhaoxing Wu, 2020

机译：Camkiiγ是通过Camkiiγ/ Stat3轴的多发性骨髓瘤的可定性驾驶员
10. Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies [O] . Christie P. M. Verkleij, Amy Jhatakia, Marloes E. C. Broekmans, 2020

机译：用于靶向PD-1 / PD-L1轴的临床终体基质与多发性骨髓瘤和其他CD38阳性恶性肿瘤中的CD38抗体组合
11. Treatment of Multiple Myeloma with VLA4-Targeted Nanoparticles Delivering Novel c-MYC Inhibitor Prodrug. [R] . Tomasson, M. 2012

机译：用VLa4靶向纳米粒子治疗多发性骨髓瘤，提供新型c-mYC抑制剂前体药物。

LRRC75A-AS1 targets miR-199b-5p/PDCD4 axis to repress multiple myeloma

摘要

著录项

相似文献

相关主题

期刊订阅